Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 100329167
Gene Symbol: AAA1
AAA1
0.010 GeneticVariation phenotype BEFREE ClpB-A328V hyperactivity is however, different from that of M-domain mutants as M-domains stay associated with the AAA-1 ring. 28275610 2017
Entrez Id: 13
Gene Symbol: AADAC
AADAC
0.010 Biomarker phenotype BEFREE The Drosophila Dac gene was cloned as an inhibitor of the hyperactive epidermal growth factor (EGFR), ellipse. 23798621 2013
Entrez Id: 10157
Gene Symbol: AASS
AASS
0.100 Biomarker phenotype HPO
Entrez Id: 18
Gene Symbol: ABAT
ABAT
0.010 GeneticVariation phenotype BEFREE Hypersomnolence-hyperkinetic movement disorder in a child with compound heterozygous mutation in 4-aminobutyrate aminotransferase (ABAT) gene. 27596361 2017
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.050 GeneticVariation phenotype BEFREE P-glycoprotein polymorphism in hypo- and hyper-thyroidism patients. 17891478 2008
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.050 Biomarker phenotype BEFREE Independently of stressor exposure, female P-gp deficient mice displayed increased depression-like behavior, idiosyncratic darting behavior, age-related social withdrawal and hyperactivity, facilitated sensorimotor gating and altered startle reactivity. 28502879 2017
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.050 Biomarker phenotype BEFREE By generating a docetaxel-cross-resistant PacR cancer cell line (PacR/DCT), we further clarified the role of FOXO3a in glycolysis-associated mediation of P-glycoprotein/ABCB1 hyperactivity that induces docetaxel cross-resistance. 28104912 2017
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.050 GeneticVariation phenotype BEFREE Subjects with either C/T or C/C (n = 16) genotypes showed a three-fold greater improvement than T/T MDR1 C3435T genotype (n = 6) (mean decrease of 15.1 +/- 12.6, or 50.7% from baseline, versus 4.5 +/- 5.1, or 15.6% from baseline) in parent-rated ABC Hyperactivity scores over 8 weeks (p = 0.03). 20166790 2010
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.050 Biomarker phenotype BEFREE These results suggest the systemic hyperactivity of P-gp in RE patients, including brain P-gp over-expression should be suspected when persistent subtherapeutic levels of AEDs in plasma are detected. 17910594 2007
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.020 GeneticVariation phenotype BEFREE In the child study, the highest dose group showed benefit over placebo on the ABC-C<sub>FX</sub> Irritability subscale (<i>p</i> = 0.03) and Parenting Stress Index (PSI, <i>p</i> = 0.03) and trends toward benefit on the ABC-C<sub>FX</sub> Social Avoidance and Hyperactivity subscales (both <i>p</i> < 0.1) and CGI-I (<i>p</i> = 0.119). 28616094 2017
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.020 Biomarker phenotype BEFREE Outcome measures included the Clinical Global Impression-Improvement (CGI-I) scale and the Aberrant Behavior Checklist (ABC-hyperactivity index). 23856854 2014
Entrez Id: 4363
Gene Symbol: ABCC1
ABCC1
0.010 Biomarker phenotype BEFREE These are the first reported results to show that berry extracts can inhibit MRP-1 function that causes apoptotic tumor cell death by accumulation of GSSG in the nucleus of EOMA cells where NADPH oxidase is hyperactive and causes pathological angiogenesis. 27706944 2017
Entrez Id: 6833
Gene Symbol: ABCC8
ABCC8
0.020 GeneticVariation phenotype BEFREE The aims of this study were to 1) investigate the expression and co-localisation of the K(ATP) channel subunits, Kir6.2 and SUR1, in human L- and K-cells and 2) investigate if a common hyperactive variant of the Kir6.2 subunit, Glu23Lys, exerts a functional impact on glucose-sensing tissues in vivo that may affect the overall glycaemic control in children with new-onset type 1 diabetes. 17535866 2007
Entrez Id: 6833
Gene Symbol: ABCC8
ABCC8
0.020 GeneticVariation phenotype BEFREE Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8). 22020219 2011
Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
0.010 AlteredExpression phenotype BEFREE These substitutions, which could be grouped into three different "hot spots," were gain of function (GOF) mutations since they conferred hyperactivity to CgPdr1p revealed by constitutive high expression of ABC-transporter genes. 19148266 2009
Entrez Id: 10006
Gene Symbol: ABI1
ABI1
0.010 Biomarker phenotype BEFREE In aggregate, our data link the loss of Abi-1 function to hyperactive SFKs/STAT3/NF-κB signaling and suggest that this signaling axis may represent a regulatory module involved in the molecular pathophysiology of PMF. 30213875 2018
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.010 Biomarker phenotype BEFREE The excessive proliferation of the myeloid marrow compartment in Philadelphia chromosome (Ph)-positive acute and chronic leukemias has been largely attributed to a hyperactive and autonomously acting hybrid tyrosine kinase BCR-ABL, a product of the fusion between the second exon of the c-ABL proto-oncogene and 5' portions of the BCR gene on chromosome 22. 9676840 1998
Entrez Id: 22885
Gene Symbol: ABLIM3
ABLIM3
0.010 AlteredExpression phenotype BEFREE Consistent with the observation of age-related hyperactivity of CA3, learning failed to increase DGC-SLIN connectivity in 17-month-old mice, whereas downregulation of ABLIM3 expression was sufficient to restore DGC-SLIN connectivity, increase PV+ SLIN activation and improve the precision of remote memories. 29529016 2018
Entrez Id: 176
Gene Symbol: ACAN
ACAN
0.010 AlteredExpression phenotype BEFREE Compared with the <i>in situ</i>-osmolarity culture, hyper-osmolarity culture significantly decreased cell proliferation and telomerase activity, increased SA-β-Gal activity and cell fraction in the G<sub>0</sub>/G<sub>1</sub> phase, up-regulated expression of senescence markers (p16 and p53) and down-regulated expression of matrix molecules (aggrecan and collagen II), and increased intracellular ROS accumulation. 31471533 2019
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.080 AlteredExpression phenotype BEFREE Angiotensin-converting enzyme (ACE) is assumed to influence the activity of the hypothalamic-pituitary-adrenocortical (HPA) axis, which shows hyperactivity in depressed patients. 24193727 2013
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.080 GeneticVariation phenotype BEFREE Benign autosomal-dominant hyper-ACE-emia should be considered for differential diagnosis of elevated ACE levels worldwide. 16958600 2006
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.080 AlteredExpression phenotype BEFREE Angiotensin-converting enzyme (ACE) is thought to influence the activity of the hypothalamic-pituitary-adrenocortical system, which shows hyperactivity in the majority of patients with major depressive disorder (MDD). 19713413 2009
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.080 Biomarker phenotype BEFREE The HPA axis stimulating properties of higher ACE and consecutively higher AT-II and/or lower substance P concentrations may be crucial factors for the HPA system hyperactivity during major depressive episodes. 12147330 2002
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.080 Biomarker phenotype BEFREE Sympathetic hyperactivity and poor sleep quality are reported in myocardial infarction (MI) patients and angiotensin-converting enzyme inhibitors (ACEI) can improve long-term survival in these patients. 29859479 2018
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.080 AlteredExpression phenotype BEFREE The T-allele of this SNP was associated with depression and depressed T-allele carriers showed higher ACE serum activity and HPA-axis hyperactivity. 16924268 2006